Wikipedia

Cadherin-1

(Redirected fromE-cadherin)

Cadherin-1orEpithelial cadherin(E-cadherin),(not to be confused with theAPC/C activator protein CDH1) is aproteinthat in humans is encoded by theCDH1gene.[5]Mutations are correlated withgastric,breast,colorectal, thyroid, and ovarian cancers. CDH1 has also been designated asCD324(cluster of differentiation324). It is atumor suppressor gene.[6][7]

CDH1
Available structures
PDBOrtholog search:PDBeRCSB
Identifiers
AliasesCDH1,Arc-1, CD324, CDHE, ECAD, LCAM, UVO, cadherin 1, BCDS1, E-cadherin, uvomorulin
External IDsOMIM:192090;MGI:88354;HomoloGene:20917;GeneCards:CDH1;OMA:CDH1 - orthologs
Orthologs
SpeciesHumanMouse
Entrez

999

12550

Ensembl

ENSG00000039068

ENSMUSG00000000303

UniProt

P12830

P09803

RefSeq (mRNA)

NM_004360
NM_001317184
NM_001317185
NM_001317186

NM_009864

RefSeq (protein)

NP_001304113
NP_001304114
NP_001304115
NP_004351

NP_033994

Location (UCSC)Chr 16: 68.74 – 68.84 MbChr 8: 107.33 – 107.4 Mb
PubMedsearch[3][4]
Wikidata
View/Edit HumanView/Edit Mouse

History

edit

The discovery of cadherin cell-cell adhesion proteins is attributed to Masatoshi Takeichi, whose experience with adhering epithelial cells began in 1966.[8]His work originally began by studying lens differentiation in chicken embryos at Nagoya University, where he explored how retinal cells regulate lens fiber differentiation. To do this, Takeichi initially collected media that had previously cultured neural retina cells (CM) and suspended lens epithelial cells in it. He observed that cells suspended in the CM media had delayed attachment compared to cells in his regular medium. His interest in cell adherence was sparked, and he moved on to examine attachment in other conditions such as in the presence of protein, magnesium, and calcium. At this point in 1970s, little was understood about the specific roles these ions played.[9]Therefore, Takeichi’s work in discovering calcium’s role in cell-cell adhesion was highly transformative.[10][11]

Takeichi went on to discover the existence of multiple cadherins, beginning with E-cadherin. Using rats immunized with F9 cells, he worked with an undergraduate student in the Okada laboratory, Noboru Suzuki, to generate mouse antibodies called ECCD1. This antibody blocked cell-adhesion ability and showed a calcium-dependent interaction with its antigen, E-cadherin.[12]They went on to find that ECCD1 reacted to a variety of epithelial cells when comparing antibody distributions.[13]The delay Takeichi experienced in specifically discovering Ecadherin was most likely due to the model he used to initially investigate cell adherence. The chinese hamster V79 cells apparently did not express E-cadherin, but instead 20 other subtypes that have since been discovered.[14]

Function

edit

Cadherin-1 is a classical member of thecadherinsuperfamily. The encoded protein is a calcium-dependent cell–cell adhesion glycoprotein composed of five extracellular cadherin repeats, a transmembrane region, and a highly conservedcytoplasmic tail.Mutations in this gene are correlated with gastric, breast, colorectal, thyroid, and ovarian cancers. Loss of function is thought to contribute to progression in cancer by increasing proliferation, invasion, and/or metastasis. The ectodomain of this protein mediates bacterial adhesion to mammalian cells, and the cytoplasmic domain is required for internalization. Identified transcript variants arise from mutation at consensus splice sites.[15]

E-cadherin (epithelial) is the most well-studied member of the cadherin family and is an essential transmembrane protein within adherens junctions. In addition to E-cadherin, adherens junctions are composed of the intracellular components,p120-catenin,beta-catenin,andAlpha -catenin.[16]Together, these proteins stabilize epithelial tissues and regulate intercellular exchange. The structure of E-cadherin consists of 5 cadherin repeats (EC1 ~ EC5) in the extracellular domain, one transmembrane domain, and a highly-phosphorylated intracellular domain. This region is vital to beta-catenin binding and, therefore, to E-cadherin function.[17]Beta-catenin can also bind to Alpha -catenin. Alpha-catenin participates in regulation ofactin-containing cytoskeletal filaments. In epithelial cells, E-cadherin-containing cell-to-cell junctions are often adjacent to actin-containing filaments of thecytoskeleton.

E-cadherin is first expressed in the 2-cell stage of mammalian development, and becomes phosphorylated by the 8-cell stage, where it causes compaction.[18]In adult tissues, E-cadherin is expressed inepithelialtissues, where it is constantly regenerated with a 5-hour half-life on the cell surface.[citation needed]Cell–cell interactions mediated by E-cadherin are crucial toblastulaformation in many animals.[19]

Neighboring epithelial cells can transduce mechanical information via E-cadherin interactions, here depicted as a generic cadherin, Actin filaments are associated with several adherens complex proteins, such as α-catenin and vinculin. The activity of these proteins and E-cadherin allows for tensile stimulus to be exerted one from actomyosin system to another, permitting tissue coordination.

Cell cycle

edit

E-cadherin has been known to mediate adhesion-dependent proliferation inhibition by triggering cell cycle exit via contact inhibition of proliferation (CIP) and recruitment of theHippo pathway.[20]E-cadherin adhesions inhibit growth signals, which initiates a kinase cascade that excludes the transcription factorYAPfrom the nucleus. Conversely, decreasing cell density (decreasing cell-cell adhesion) or applying mechanical stretch to place E-cadherins under increased tension promotes cell cycle entry and YAP nuclear localization.[21]

Cell sorting during epithelial budding

edit

E-cadherin has been found to have a role in epithelial morphogenesis and branching, such as during the formation of epithelial buds. Physiologically, branching is an important feature that allows tissues, such as salivary glands and pancreatic buds, to maximize functional surface areas.[22]It has been discovered that the application of appropriate growth factors and extracellular matrix can induce branching in tissue, but the mechanisms of branching appear to differ between single-layered and stratified epithelium.[23][24]

Single-layered branching occurs as nearby mechanical influences, such as airway smooth muscle cells, cause epithelial sheets buckle.[25]Stratified epithelial cannot respond to stimulus in the same way due to the absence of internal space (i.e. lumen) that allows tissue sheet flexibility.[26]Instead, it appears stratified epithelial buds are generated by the clefting of one original epithelial cell cluster. Investigations in salivary glands revealed that buds expand as new cells are uniformly distributed across the peripheral surface. Surface-derived cells continue to replicate and produce daughter cells, which then move from the interior back to the surface. This movement is maintained by an E-cadherin gradient, in which surface cells have low levels of E-cadherin and interior cells have high levels of E-cadherin. Such a system allows for increased interactions between interior cells, limiting mobility and ensuring they remain more static, while likewise ensuring the surface cells are comparatively less hindered. This gives a fluidity to their movement within the stratified epithelia, until they begin to accumulate at the edges of the forming bud.[27]

While this gradient is important for cell sorting within the tissue layers, additional experiments show that the physical generation of buds is dependent on cell-matrix interactions[13].As low-E-cadherin cells accumulate at the surface, they tightly adhere to the basement membrane, allowing the epithelia to cleft and bud as the surface area expands and folds. If the structure of the basement membrane is disrupted, such as by collagenase, the low-E-cadherin cells no longer have a barrier to interact with. Surface-derived daughter cells fail to remain at the periphery to initiate budding under these conditions, yet budding can be reestablished with basement membrane restoration.

Cell sorting during gastrulation

edit

The adhesive qualities of E-cadherin indicate it could be a relevant player within germ-layer organization duringgastrulation.Gastrulation is a fundamental phase of vertebrate development in which three primary germ layers are defined,ectoderm,mesoderm,andendoderm.[28]Cell adhesion has been linked to progenitor sorting, where ectoderm was found to be the least cohesive and mesoderm was comparable to endoderm cohesion.[29]Initial work depleting calcium from media and, more strikingly, the impairment of E-cadherin both greatly impaired primary germ layer cohesion. As cohesive properties of progenitors were further examined, higher concentrations of CDH-1 were found on mesoderm or endoderm than on ectoderm. While adhesion is a factor in gastrulation, the driving factor in cell sorting was instead found to be in cell-cortex tension[15].Disrupting the actomyosin-dependent cell cortex with actin depolymerizers and myosin-II inhibitors interrupted impeded tension balances and was sufficient to inhibit cell sorting. This is likely because cell sorting is driven by energy minimization. WIthin tissue energetics, tension plays an important role in ensuring: (1) lower surface tension surrounds the higher surface tension germ layers; (2) aggregate surface tension is appropriately increased; and (3) tension is higher at the cell-to-medium interface than cell-to-cell interface[8]. Cellular adhesion must still be considered for a complete understanding of progenitor sorting, as it directly diminishes the energetic effects of tension. Combined, tension and adhesion increase aggregate surface tension, which allows for unique interactions between differing germ layers and appropriate cell sorting.[30]

Cell migration

edit

Cell migration is vital for constructing and maintaining multicellular organization. Morphogenesis involves numerous events of cell migration, such as the migration of epithelial sheets in gastrulation, the neural crest cell migration, or posterior lateral line primordium migration.[31]It is known that cells that begin to internalize at the dorsal surface of the embryo mobilize to extend the axis and direct posterior prechordal plate and notochord precursors. How cells are able to orient themselves during this process is dependent on the protrusions of “follower cells” to guide the leading cells in the appropriate direction.[32]

E-cadherin has an active role in collective cell dynamics, such as by directing the migration of mesendoderm towards the animal pole.[33]It has been demonstrated that the genetic knockdown of E-cadherin results in random orientations of the cellular protrusions, resulting in cellular migration that is random and no longer unified.[34]Knockdowns in leading and following cell groups both resulted in a loss of orientation, which could be rescued by re-expressing E-cadherin. The information E-cadherin transmitted from cell to cell was directional information inherent to cytoskeletal tension. Restoring only the external adhesion capability of E-cadherin was not enough to rescue protrusion orientation during knockdown experiments. The intracellular domain of E-cadherin is essential due to its mechanotransduction characteristics; it interacts with Alpha -catenin and vinculin and altogether allows for the mechanosensation of tension.[35][36][37]The exact mechanism on how mechanosensation directs actin-rich protrusions is yet to be elucidated, however initial investigations suggest regulation ofPI3Kactivity is involved.[32]

Force transduction by E-cadherin

edit

Adherens junctions (AJs) form homotypic dimers between neighboring cells, where the intracellular protein complex interacts with the actomyosin cytoskeleton. p120-catenin controls E-cadherin membrane localization, while β-catenin and α-catenin provide the link that connect AJs to the cytoskeleton. If AJs experience tensile force when β-catenin is bound, the interaction, known as a catch bond interaction, between α-catenin and F-actin is reinforced. This exposes the a previously inaccessible actin binding site within α-catenin.[38]The binding of vinculin to α-catenin offers the protein complex another linkage with actin in addition to recruiting proteins such as Mena/VASP.[39]

Coordination of the actomyosin network between neighboring cells permits collective cellular activity, such as contractility during morphogenesis. This network is better equipped to maintain tissue integrity if under intercellular stress, but should not be considered a static system. E-cadherin is involved in cellular responses and transcriptional activators that impact migration, growth, and reorganization.[40][41]

Mechanism of action

edit

E-cadherin interacts with its environment through numerous pathways. One mechanism that it is involved in is the migration of tissue sheets via cryptic lamellipodia. Rac1 and its effectors act at the front edge of this structure to initiate actin polymerization, allowing the cell to generate force at the cellular margin and forward movement.[42]As leader cells extend their lamellipodia, followers also extend protrusions to collect information on where the tissue sheet it moving. Cell migration is dependent on the generation of a polarized state, with Rac1 at the front and Rho-mediated adhesion at the rear. The release of Merlin from cell contacts partially mediates concomitant migration by acting as a mechanochemical transducer.[43]This tumour suppressor protein relocalizes from cortical cell-cell junctions to the cytoplasm during migration to coordinate Rac1 activation. Other pathways can then modulate Merlin activity, such as circumferential actin belts, which suppresses the nuclear export of Merlin and its interaction with E-cadherin.[44]

Interactions

edit

CDH1 (gene) has been shown tointeractwith

Clinical significance

edit
Immunohistochemistryfor E-cadherin in invasive lobular carcinoma, showing loss of expression in invasive tumor cells (white arrow).

Loss of E-cadherin function or expression has been implicated incancerprogression andmetastasis.[62][63]E-cadherin downregulation decreases the strength of cellular adhesion within a tissue, resulting in an increase in cellular motility. This in turn may allow cancer cells to cross thebasement membraneand invade surrounding tissues.[63]E-cadherin is also used by pathologists to diagnose different kinds of breast cancer. When compared with invasiveductal carcinoma,E-cadherin expression is markedly reduced or absent in the great majority ofinvasive lobular carcinomaswhen studied byimmunohistochemistry.[64]E-cadherin and N-cadherin temporal-spatial expression are tightly regulated during cranial suture fusion in craniofacial development.[65]

Cancer

edit

Metastasis

edit

Transitions between epithelial and mesenchymal states play important roles in embryonic development and cancer metastasis. E-cadherin level changes in EMT (epithelial-mesenchymal transition) and MET (mesenchymal-epithelial transition). E-cadherin acts as an invasion suppressor and a classical tumor suppressor gene in pre-invasive lobular breast carcinoma.[66]

EMT

edit

E-cadherin is a crucial type of cell–cell adhesion to hold the epithelial cells tight together. E-cadherin can sequester β-catenin on the cell membrane by the cytoplasmic tail of E-cadherin. Loss of E-cadherin expression results in releasing β-catenin into the cytoplasm. Liberated β-catenin molecules may migrate into the nucleus and trigger the expression of EMT-inducing transcription factors. Together with other mechanisms, such as constitutive RTK activation, E-cadherin loss can lead cancer cells to the mesenchymal state and undergo metastasis. E-cadherin is an important switch in EMT.[66]

MET

edit

The mesenchymal state cancer cells migrate to new sites and may undergo METs in certain favorable microenvironment. For example, the cancer cells can recognize differentiated epithelial cell features in the new sites and upregulate E-cadherin expression. Those cancer cells can form cell–cell adhesions again and return to an epithelial state.[66]

Examples

edit
  • Inherited inactivating mutations in CDH1 are associated withhereditary diffuse gastric cancer.Individuals with this condition have up to a 70% lifetime risk of developing diffuse gastric carcinoma, and females with CDH1 mutations have up to a 60% lifetime risk of developing lobular breast cancer.[67]
  • Inactivation of CDH1 (accompanied withloss of the wild-type allele) in 56% of lobular breast carcinomas.[68][69]
  • Inactivation of CDH1 in 50% of diffuse gastric carcinomas.[70]
  • Complete loss of E-cadherin protein expression in 84% of lobular breast carcinomas.[71]

Genetic and epigenetic control

edit

Several proteins such asSNAI1,[72][73]ZEB2,[74]SNAI2,[75][76]TWIST1[77]andZEB1[78]have been found to downregulate E-cadherin expression. When expression of those transcription factors is altered, transcriptional repressors of E-cadherin were overexpressed in tumor cells. Another group of genes, such as AML1, p300 and HNF3,[79]can upregulate the expression of E-cadherin.[80]

In order to study the epigenetic regulation of E-cadherin, M Lombaerts et al. performed a genome wide expression study on 27 human mammary cell lines. Their results revealed two main clusters that have the fibroblastic or epithelial phenotype, respectively. In close examination, the clusters showing fibroblast phenotypes only have either partial or complete CDH1 promoter methylation, while the clusters with epithelial phenotypes have both wild-type cell lines and cell lines with mutant CDH1 status. The authors also found that EMT can happen in breast cancer cell lines with hypermethylation of CDH1 promoter, but in breast cancer cell lines with a CDH1 mutational inactivation EMT cannot happen. It contradicts the hypothesis that E-cadherin loss is the initial or primary cause for EMT. In conclusion, the results suggest that “E-cadherin transcriptional inactivation is an epi-phenomenon and part of an entire program, with much more severe effects than loss of E-cadherin expression alone”.[80]

Other studies also show that epigenetic regulation of E-cadherin expression occurs during metastasis. The methylation patterns of the E-cadherin 5’ CpG island are not stable. During metastatic progression of many cases of epithelial tumors, a transient loss of E-cadherin is seen and the heterogeneous loss of E-cadherin expression results from a heterogeneous pattern of promoter region methylation of E-cadherin.[81]

See also

edit

References

edit
  1. ^abcGRCh38: Ensembl release 89: ENSG00000039068–Ensembl,May 2017
  2. ^abcGRCm38: Ensembl release 89: ENSMUSG00000000303–Ensembl,May 2017
  3. ^"Human PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  4. ^"Mouse PubMed Reference:".National Center for Biotechnology Information, U.S. National Library of Medicine.
  5. ^Huntsman DG, Caldas C (Mar 1999). "Assignment1 of the E-cadherin gene (CDH1) to chromosome 16q22.1 by radiation hybrid mapping".Cytogenetics and Cell Genetics.83(1–2): 82–83.doi:10.1159/000015134.PMID9925936.S2CID39971762.
  6. ^Semb H, Christofori G (December 1998)."The tumor-suppressor function of E-cadherin".American Journal of Human Genetics.63(6): 1588–93.doi:10.1086/302173.PMC1377629.PMID9837810.
  7. ^Wong AS, Gumbiner BM (June 2003)."Adhesion-independent mechanism for suppression of tumor cell invasion by E-cadherin".The Journal of Cell Biology.161(6): 1191–1203.doi:10.1083/jcb.200212033.PMC2173007.PMID12810698.
  8. ^Takeichi M (January 2018)."Historical review of the discovery of cadherin, in memory of Tokindo Okada".Development, Growth & Differentiation.60(1): 3–13.doi:10.1111/dgd.12416.PMID29278270.S2CID20240634.
  9. ^Takeichi M, Ozaki HS, Tokunaga K, Okada TS (May 1979). "Experimental manipulation of cell surface to affect cellular recognition mechanisms".Developmental Biology.70(1): 195–205.doi:10.1016/0012-1606(79)90016-2.PMID456740.
  10. ^Urushihara H, Ozaki HS, Takeichi M (May 1979). "Immunological detection of cell surface components related with aggregation of Chinese hamster and chick embryonic cells".Developmental Biology.70(1): 206–216.doi:10.1016/0012-1606(79)90017-4.PMID110634.
  11. ^Urushihara H, Takeichi M (June 1980). "Cell-cell adhesion molecule: identification of a glycoprotein relevant to the Ca2+-independent aggregation of Chinese hamster fibroblasts ".Cell.20(2): 363–371.doi:10.1016/0092-8674(80)90622-4.PMID7388946.S2CID39836422.
  12. ^Yoshida-Noro C, Suzuki N, Takeichi M (January 1984). "Molecular nature of the calcium-dependent cell-cell adhesion system in mouse teratocarcinoma and embryonic cells studied with a monoclonal antibody".Developmental Biology.101(1): 19–27.doi:10.1016/0012-1606(84)90112-X.PMID6692973.
  13. ^Lampugnani MG, Resnati M, Raiteri M, Pigott R, Pisacane A, Houen G, et al. (September 1992)."A novel endothelial-specific membrane protein is a marker of cell-cell contacts".The Journal of Cell Biology.118(6): 1511–22.doi:10.1083/jcb.118.6.1511.PMC2289607.PMID1522121.
  14. ^Takeichi M (November 1977)."Functional correlation between cell adhesive properties and some cell surface proteins".The Journal of Cell Biology.75(2 Pt 1): 464–474.doi:10.1083/jcb.75.2.464.PMC2109947.PMID264120.
  15. ^"Entrez Gene: CDH1 cadherin 1, type 1, E-cadherin (epithelial)".
  16. ^Hartsock A, Nelson WJ (March 2008)."Adherens and tight junctions: structure, function and connections to the actin cytoskeleton".Biochimica et Biophysica Acta (BBA) - Biomembranes.Apical Junctional Complexes Part I.1778(3): 660–9.doi:10.1016/j.bbamem.2007.07.012.PMC2682436.PMID17854762.
  17. ^Faux MC, Coates JL, Kershaw NJ, Layton MJ, Burgess AW (November 2010)."Independent interactions of phosphorylated β-catenin with E-cadherin at cell-cell contacts and APC at cell protrusions".PLOS ONE.5(11): e14127.Bibcode:2010PLoSO...514127F.doi:10.1371/journal.pone.0014127.PMC2994709.PMID21152425.
  18. ^Hyafil F, Babinet C, Jacob F (1981). "Cell-cell interactions in early embryogenesis: a molecular approach to the role of calcium".Cell.26(3 Pt 1): 447–454.doi:10.1016/0092-8674(81)90214-2.PMID6976838.S2CID40534936.
  19. ^Fleming TP, Papenbrock T, Fesenko I, Hausen P, Sheth B (August 2000). "Assembly of tight junctions during early vertebrate development".Seminars in Cell & Developmental Biology.11(4): 291–9.doi:10.1006/scdb.2000.0179.PMID10966863.
  20. ^McClatchey AI, Yap AS (October 2012). "Contact inhibition (of proliferation) redux".Current Opinion in Cell Biology.Cell-to-cell contact and extracellular matrix.24(5): 685–694.doi:10.1016/j.ceb.2012.06.009.PMID22835462.
  21. ^Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, Rodriguez JR, Zhou D, et al. (March 2011)."Yap1 acts downstream of α-catenin to control epidermal proliferation".Cell.144(5): 782–795.doi:10.1016/j.cell.2011.02.031.PMC3237196.PMID21376238.
  22. ^Wang S, Sekiguchi R, Daley WP, Yamada KM (March 2017)."Patterned cell and matrix dynamics in branching morphogenesis".The Journal of Cell Biology.216(3): 559–570.doi:10.1083/jcb.201610048.PMC5350520.PMID28174204.
  23. ^Nogawa H, Ito T (April 1995). "Branching morphogenesis of embryonic mouse lung epithelium in mesenchyme-free culture".Development.121(4): 1015–22.doi:10.1242/dev.121.4.1015.PMID7538066.
  24. ^Ewald AJ, Brenot A, Duong M, Chan BS, Werb Z (April 2008)."Collective epithelial migration and cell rearrangements drive mammary branching morphogenesis".Developmental Cell.14(4): 570–581.doi:10.1016/j.devcel.2008.03.003.PMC2773823.PMID18410732.
  25. ^Kim HY, Pang MF, Varner VD, Kojima L, Miller E, Radisky DC, Nelson CM (September 2015)."Localized Smooth Muscle Differentiation Is Essential for Epithelial Bifurcation during Branching Morphogenesis of the Mammalian Lung".Developmental Cell.34(6): 719–726.doi:10.1016/j.devcel.2015.08.012.PMC4589145.PMID26387457.
  26. ^Nelson CM (February 2016)."On Buckling Morphogenesis".Journal of Biomechanical Engineering.138(2): 021005.doi:10.1115/1.4032128.PMC4844087.PMID26632268.
  27. ^Wang S, Matsumoto K, Lish SR, Cartagena-Rivera AX, Yamada KM (July 2021)."Budding epithelial morphogenesis driven by cell-matrix versus cell-cell adhesion".Cell.184(14): 3702–16.e30.doi:10.1016/j.cell.2021.05.015.PMC8287763.PMID34133940.
  28. ^Shimizu T, Yabe T, Muraoka O, Yonemura S, Aramaki S, Hatta K, et al. (June 2005). "E-cadherin is required for gastrulation cell movements in zebrafish".Mechanisms of Development.122(6): 747–763.doi:10.1016/j.mod.2005.03.008.PMID15905076.S2CID16117456.
  29. ^Krieg M, Arboleda-Estudillo Y, Puech PH, Käfer J, Graner F, Müller DJ, Heisenberg CP (April 2008). "Tensile forces govern germ-layer organization in zebrafish".Nature Cell Biology.10(4): 429–436.doi:10.1038/ncb1705.PMID18364700.S2CID22340931.
  30. ^Lecuit T, Lenne PF (August 2007). "Cell surface mechanics and the control of cell shape, tissue patterns and morphogenesis".Nature Reviews. Molecular Cell Biology.8(8): 633–644.doi:10.1038/nrm2222.PMID17643125.S2CID1376635.
  31. ^Olson HM, Nechiporuk AV (2018)."Using Zebrafish to Study Collective Cell Migration in Development and Disease".Frontiers in Cell and Developmental Biology.6:83.doi:10.3389/fcell.2018.00083.PMC6107837.PMID30175096.
  32. ^abBoutillon A, Escot S, Elouin A, Jahn D, González-Tirado S, Starruß J, et al. (June 2022)."Guidance by followers ensures long-range coordination of cell migration through α-catenin mechanoperception".Developmental Cell.57(12): 1529–44.doi:10.1016/j.devcel.2022.05.001.PMID35613615.
  33. ^Bazellières E, Conte V, Elosegui-Artola A, Serra-Picamal X, Bintanel-Morcillo M, Roca-Cusachs P, et al. (April 2015)."Control of cell-cell forces and collective cell dynamics by the intercellular adhesome".Nature Cell Biology.17(4): 409–420.doi:10.1038/ncb3135.hdl:2117/76589.PMC4886824.PMID25812522.
  34. ^Dumortier JG, Martin S, Meyer D, Rosa FM, David NB (October 2012)."Collective mesendoderm migration relies on an intrinsic directionality signal transmitted through cell contacts".Proceedings of the National Academy of Sciences of the United States of America.109(42): 16945–50.Bibcode:2012PNAS..10916945D.doi:10.1073/pnas.1205870109.PMC3479507.PMID23027928.
  35. ^Grashoff C, Hoffman BD, Brenner MD, Zhou R, Parsons M, Yang MT, et al. (July 2010)."Measuring mechanical tension across vinculin reveals regulation of focal adhesion dynamics".Nature.466(7303): 263–6.Bibcode:2010Natur.466..263G.doi:10.1038/nature09198.PMC2901888.PMID20613844.
  36. ^Hoffman BD, Yap AS (December 2015). "Towards a Dynamic Understanding of Cadherin-Based Mechanobiology".Trends in Cell Biology.Special Issue: Quantitative Cell Biology.25(12): 803–814.doi:10.1016/j.tcb.2015.09.008.PMID26519989.
  37. ^Ladoux B, Nelson WJ, Yan J, Mège RM (October 2015)."The mechanotransduction machinery at work at adherens junctions".Integrative Biology.7(10): 1109–19.doi:10.1039/c5ib00070j.PMC4593723.PMID25968913.
  38. ^Ishiyama N, Sarpal R, Wood MN, Barrick SK, Nishikawa T, Hayashi H, et al. (November 2018)."Force-dependent allostery of the α-catenin actin-binding domain controls adherens junction dynamics and functions".Nature Communications.9(1): 5121.Bibcode:2018NatCo...9.5121I.doi:10.1038/s41467-018-07481-7.PMC6269467.PMID30504777.
  39. ^Leerberg JM, Gomez GA, Verma S, Moussa EJ, Wu SK, Priya R, et al. (August 2014)."Tension-sensitive actin assembly supports contractility at the epithelial zonula adherens".Current Biology.24(15): 1689–99.Bibcode:2014CBio...24.1689L.doi:10.1016/j.cub.2014.06.028.PMC5103636.PMID25065757.
  40. ^Hart KC, Tan J, Siemers KA, Sim JY, Pruitt BL, Nelson WJ, Gloerich M (July 2017)."E-cadherin and LGN align epithelial cell divisions with tissue tension independently of cell shape".Proceedings of the National Academy of Sciences of the United States of America.114(29): E5845–E5853.Bibcode:2017PNAS..114E5845H.doi:10.1073/pnas.1701703114.PMC5530667.PMID28674014.
  41. ^Benham-Pyle BW, Pruitt BL, Nelson WJ (May 2015)."Cell adhesion. Mechanical strain induces E-cadherin-dependent Yap1 and β-catenin activation to drive cell cycle entry".Science.348(6238): 1024–7.Bibcode:2015Sci...348.1024B.doi:10.1126/science.aaa4559.PMC4572847.PMID26023140.
  42. ^Ozawa M, Hiver S, Yamamoto T, Shibata T, Upadhyayula S, Mimori-Kiyosue Y, Takeichi M (October 2020)."Adherens junction regulates cryptic lamellipodia formation for epithelial cell migration".The Journal of Cell Biology.219(10).doi:10.1083/jcb.202006196.PMC7659716.PMID32886101.
  43. ^Das T, Safferling K, Rausch S, Grabe N, Boehm H, Spatz JP (March 2015). "A molecular mechanotransduction pathway regulates collective migration of epithelial cells".Nature Cell Biology.17(3): 276–287.doi:10.1038/ncb3115.PMID25706233.S2CID772049.
  44. ^Furukawa KT, Yamashita K, Sakurai N, Ohno S (August 2017)."The Epithelial Circumferential Actin Belt Regulates YAP/TAZ through Nucleocytoplasmic Shuttling of Merlin".Cell Reports.20(6): 1435–47.doi:10.1016/j.celrep.2017.07.032.PMID28793266.
  45. ^Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, Behrens J, et al. (March 2002). "Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex".Nature Cell Biology.4(3): 222–231.doi:10.1038/ncb758.PMID11836526.S2CID40423770.
  46. ^Vodermaier HC, Gieffers C, Maurer-Stroh S, Eisenhaber F, Peters JM (September 2003)."TPR subunits of the anaphase-promoting complex mediate binding to the activator protein CDH1".Current Biology.13(17): 1459–68.Bibcode:2003CBio...13.1459V.doi:10.1016/S0960-9822(03)00581-5.PMID12956947.S2CID5942532.
  47. ^Klingelhöfer J, Troyanovsky RB, Laur OY, Troyanovsky S (August 2000). "Amino-terminal domain of classic cadherins determines the specificity of the adhesive interactions".Journal of Cell Science.113(16): 2829–36.doi:10.1242/jcs.113.16.2829.PMID10910767.
  48. ^Davies G, Jiang WG, Mason MD (April 2001). "HGF/SF modifies the interaction between its receptor c-Met, and the E-cadherin/catenin complex in prostate cancer cells".International Journal of Molecular Medicine.7(4): 385–8.doi:10.3892/ijmm.7.4.385.PMID11254878.
  49. ^Daniel JM, Reynolds AB (September 1995)."The tyrosine kinase substrate p120cas binds directly to E-cadherin but not to the adenomatous polyposis coli protein or Alpha -catenin".Molecular and Cellular Biology.15(9): 4819–24.doi:10.1128/mcb.15.9.4819.PMC230726.PMID7651399.
  50. ^Kucerová D, Sloncová E, Tuhácková Z, Vojtechová M, Sovová V (December 2001). "Expression and interaction of different catenins in colorectal carcinoma cells".International Journal of Molecular Medicine.8(6): 695–8.doi:10.3892/ijmm.8.6.695.PMID11712088.
  51. ^Navarro P, Lozano E, Cano A (August 1993). "Expression of E- or P-cadherin is not sufficient to modify the morphology and the tumorigenic behavior of murine spindle carcinoma cells. Possible involvement of plakoglobin".Journal of Cell Science.105(4): 923–934.doi:10.1242/jcs.105.4.923.hdl:10261/78716.PMID8227214.
  52. ^Laoukili J, Alvarez-Fernandez M, Stahl M, Medema RH (September 2008)."FoxM1 is degraded at mitotic exit in a Cdh1-dependent manner".Cell Cycle.7(17): 2720–6.doi:10.4161/cc.7.17.6580.PMID18758239.
  53. ^abYoon YM, Baek KH, Jeong SJ, Shin HJ, Ha GH, Jeon AH, et al. (September 2004)."WD repeat-containing mitotic checkpoint proteins act as transcriptional repressors during interphase".FEBS Letters.575(1–3): 23–29.doi:10.1016/j.febslet.2004.07.089.PMID15388328.S2CID21762011.
  54. ^Li Z, Kim SH, Higgins JM, Brenner MB, Sacks DB (December 1999)."IQGAP1 and calmodulin modulate E-cadherin function".The Journal of Biological Chemistry.274(53): 37885–92.doi:10.1074/jbc.274.53.37885.PMID10608854.
  55. ^Piedra J, Miravet S, Castaño J, Pálmer HG, Heisterkamp N, García de Herreros A, Duñach M (April 2003)."p120 Catenin-associated Fer and Fyn tyrosine kinases regulate beta-catenin Tyr-142 phosphorylation and beta-catenin- Alpha -catenin Interaction".Molecular and Cellular Biology.23(7): 2287–97.doi:10.1128/MCB.23.7.2287-2297.2003.PMC150740.PMID12640114.
  56. ^Nourry C, Maksumova L, Pang M, Liu X, Wang T (May 2004)."Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1".BMC Cell Biology.5(1): 20.doi:10.1186/1471-2121-5-20.PMC420458.PMID15144564.
  57. ^Knudsen KA, Wheelock MJ (August 1992)."Plakoglobin, or an 83-kD homologue distinct from beta-catenin, interacts with E-cadherin and N-cadherin".The Journal of Cell Biology.118(3): 671–9.doi:10.1083/jcb.118.3.671.PMC2289540.PMID1639850.
  58. ^Hazan RB, Kang L, Roe S, Borgen PI, Rimm DL (December 1997)."Vinculin is associated with the E-cadherin adhesion complex".The Journal of Biological Chemistry.272(51): 32448–53.doi:10.1074/jbc.272.51.32448.PMID9405455.
  59. ^Brady-Kalnay SM, Rimm DL, Tonks NK (August 1995)."Receptor protein tyrosine phosphatase PTPmu associates with cadherins and catenins in vivo".The Journal of Cell Biology.130(4): 977–986.doi:10.1083/jcb.130.4.977.PMC2199947.PMID7642713.
  60. ^Brady-Kalnay SM, Mourton T, Nixon JP, Pietz GE, Kinch M, Chen H, et al. (April 1998)."Dynamic interaction of PTPmu with multiple cadherins in vivo".The Journal of Cell Biology.141(1): 287–296.doi:10.1083/jcb.141.1.287.PMC2132733.PMID9531566.
  61. ^Besco JA, Hooft van Huijsduijnen R, Frostholm A, Rotter A (October 2006). "Intracellular substrates of brain-enriched receptor protein tyrosine phosphatase rho (RPTPrho/PTPRT)".Brain Research.1116(1): 50–57.doi:10.1016/j.brainres.2006.07.122.PMID16973135.S2CID23343123.
  62. ^Beavon IR (August 2000). "The E-cadherin-catenin complex in tumour metastasis: structure, function and regulation".European Journal of Cancer.36(13 Spec No): 1607–20.doi:10.1016/S0959-8049(00)00158-1.PMID10959047.
  63. ^abWeinberg R (2006).The Biology of Cancer.Garland Science.ISBN978-0-8153-4078-2.OCLC1450302052.
  64. ^Rosen P (2009).Rosen's Breast Pathology(3rd ed.). Lippincott Williams & Wilkins. p. 704.ISBN978-1-4698-7957-4.OCLC308164852.
  65. ^Sahar DE, Behr B, Fong KD, Longaker MT, Quarto N (2010)."Unique modulation of cadherin expression pattern during posterior frontal cranial suture development and closure".Cells Tissues Organs.191(5): 401–13.doi:10.1159/000272318.PMC2859230.PMID20051668.
  66. ^abcPolyak K, Weinberg RA (April 2009). "Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits".Nature Reviews. Cancer.9(4): 265–273.doi:10.1038/nrc2620.PMID19262571.S2CID3336730.
  67. ^van der Post RS, Vogelaar IP, Carneiro F, Guilford P, Huntsman D, Hoogerbrugge N, et al. (June 2015)."Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers".Journal of Medical Genetics.52(6): 361–374.doi:10.1136/jmedgenet-2015-103094.PMC4453626.PMID25979631.
  68. ^Berx G, Cleton-Jansen AM, Nollet F, de Leeuw WJ, van de Vijver M, Cornelisse C, van Roy F (December 1995)."E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers".The EMBO Journal.14(24): 6107–15.doi:10.1002/j.1460-2075.1995.tb00301.x.PMC394735.PMID8557030.
  69. ^Berx G, Cleton-Jansen AM, Strumane K, de Leeuw WJ, Nollet F, van Roy F, Cornelisse C (November 1996). "E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain".Oncogene.13(9): 1919–25.PMID8934538.
  70. ^Becker KF, Atkinson MJ, Reich U, Becker I, Nekarda H, Siewert JR, Höfler H (July 1994). "E-cadherin gene mutations provide clues to diffuse type gastric carcinomas".Cancer Research.54(14): 3845–52.PMID8033105.
  71. ^De Leeuw WJ, Berx G, Vos CB, Peterse JL, Van de Vijver MJ, Litvinov S, et al. (December 1997). "Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ".The Journal of Pathology.183(4): 404–411.doi:10.1002/(SICI)1096-9896(199712)183:4<404::AID-PATH1148>3.0.CO;2-9.PMID9496256.S2CID25793212.
  72. ^Batlle E, Sancho E, Francí C, Domínguez D, Monfar M, Baulida J, García De Herreros A (February 2000). "The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells".Nature Cell Biology.2(2): 84–89.doi:10.1038/35000034.PMID10655587.S2CID23809509.
  73. ^Cano A, Pérez-Moreno MA, Rodrigo I, Locascio A, Blanco MJ, del Barrio MG, et al. (February 2000). "The transcription factor snail controls epithelial-mesenchymal transitions by repressing E-cadherin expression".Nature Cell Biology.2(2): 76–83.doi:10.1038/35000025.hdl:10261/32314.PMID10655586.S2CID28329186.
  74. ^Comijn J, Berx G, Vermassen P, Verschueren K, van Grunsven L, Bruyneel E, et al. (June 2001)."The two-handed E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion".Molecular Cell.7(6): 1267–78.doi:10.1016/S1097-2765(01)00260-X.PMID11430829.
  75. ^Hajra KM, Chen DY, Fearon ER (March 2002). "The SLUG zinc-finger protein represses E-cadherin in breast cancer".Cancer Research.62(6): 1613–8.PMID11912130.
  76. ^De Craene B, Gilbert B, Stove C, Bruyneel E, van Roy F, Berx G (July 2005)."The transcription factor snail induces tumor cell invasion through modulation of the epithelial cell differentiation program"(PDF).Cancer Research.65(14): 6237–44.doi:10.1158/0008-5472.CAN-04-3545.PMID16024625.
  77. ^Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, et al. (June 2004)."Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis".Cell.117(7): 927–939.doi:10.1016/j.cell.2004.06.006.PMID15210113.S2CID16181905.
  78. ^Eger A, Aigner K, Sonderegger S, Dampier B, Oehler S, Schreiber M, et al. (March 2005)."DeltaEF1 is a transcriptional repressor of E-cadherin and regulates epithelial plasticity in breast cancer cells".Oncogene.24(14): 2375–85.doi:10.1038/sj.onc.1208429.PMID15674322.S2CID25818909.
  79. ^Liu YN, Lee WW, Wang CY, Chao TH, Chen Y, Chen JH (December 2005). "Regulatory mechanisms controlling human E-cadherin gene expression".Oncogene.24(56): 8277–90.doi:10.1038/sj.onc.1208991.PMID16116478.S2CID12243779.
  80. ^abLombaerts M, van Wezel T, Philippo K, Dierssen JW, Zimmerman RM, Oosting J, et al. (March 2006)."E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines".British Journal of Cancer.94(5): 661–671.doi:10.1038/sj.bjc.6602996.PMC2361216.PMID16495925.
  81. ^Graff JR, Gabrielson E,Fujii H,Baylin SB,Herman JG(January 2000)."Methylation patterns of the E-cadherin 5' CpG island are unstable and reflect the dynamic, heterogeneous loss of E-cadherin expression during metastatic progression".The Journal of Biological Chemistry.275(4): 2727–32.doi:10.1074/jbc.275.4.2727.PMID10644736.

Further reading

edit
edit

This article incorporates text from theUnited States National Library of Medicine,which is in thepublic domain.

Retrieved from "https://en.wikipedia.org/w/index.php?title=Cadherin-1&oldid=1250059065"